GIFT a SubscriptionGift
HamberMenu
  1. Cricket
  2. Data
  3. Health
  4. Opinion
  5. SEARCH Icon
  1. Cricket
  2. Data
  3. Health
  4. Opinion
  5. SEARCH Icon

To enjoy additional benefits

GIFT a SubscriptionGift
ShowcaseCrossword+

CONNECT WITH US

year
Click here for our in-depth coverage of Lok Sabha and Assembly elections #ElectionsWithTheHindu

Suven Pharma Q2 profit rises 31% to ₹97 cr.

November 07, 2021 05:03 am | Updated 05:03 am IST - NEW DELHI

PTI

Suven Pharmaceuticals on Saturday posted a 31% increase in its consolidated net profit to ₹97 crore for the second quarter ended September 30.

Revenue from operations rose to ₹301 crore for the quarter under review, as against ₹237 crore in the year-earlier period, Suven Pharmaceuticals said in a regulatory filing.

The COVID-19 pandemic continues to impact the business and research in India and its wholly owned subsidiary, Suven Pharma Inc. USA, it noted.

The firm primarily operates in the contract development and manufacturing operations segment.

Top News Today

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.